Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus. [electronic resource]
- Scientific reports 11 2017
- 16072 p. digital
Publication Type: Journal Article
2045-2322
10.1038/s41598-017-16405-2 doi
Allosteric Site Animals Diabetes Mellitus, Type 2--drug therapy Enzyme Activators--chemical synthesis Female Glucokinase--metabolism Humans Male Molecular Docking Simulation Pyridoxine--chemical synthesis Rats Toxicity Tests, Acute